Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 not only rewire cellular metabolic pathways but also reshape epigenetic landscapes to promote tumorigenesis, acting as key drivers in various cancers. Here, IDH2 is linked to cancer.